InTrack Investment Management Inc decreased its holdings in shares of Xylem Inc. (NYSE:XYL – Free Report) by 27.7% in the 1st quarter, Holdings Channel.com reports. The institutional investor owned 8,108 shares of the industrial products company’s stock after selling 3,101 shares during the period. InTrack Investment Management Inc’s holdings in Xylem were worth $1,048,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Vanguard Group Inc. grew its holdings in shares of Xylem by 0.7% during the fourth quarter. Vanguard Group Inc. now owns 28,048,996 shares of the industrial products company’s stock worth $3,207,683,000 after purchasing an additional 187,847 shares in the last quarter. Morgan Stanley increased its holdings in shares of Xylem by 11.5% in the 3rd quarter. Morgan Stanley now owns 4,528,905 shares of the industrial products company’s stock worth $412,267,000 after buying an additional 466,911 shares during the last quarter. Royal Bank of Canada raised its position in shares of Xylem by 10.6% during the 3rd quarter. Royal Bank of Canada now owns 3,408,200 shares of the industrial products company’s stock valued at $310,249,000 after buying an additional 327,383 shares in the last quarter. Baillie Gifford & Co. lifted its holdings in shares of Xylem by 2.3% during the 4th quarter. Baillie Gifford & Co. now owns 3,066,639 shares of the industrial products company’s stock worth $350,701,000 after acquiring an additional 69,619 shares during the last quarter. Finally, Victory Capital Management Inc. grew its position in Xylem by 0.7% in the fourth quarter. Victory Capital Management Inc. now owns 2,527,487 shares of the industrial products company’s stock worth $289,043,000 after acquiring an additional 16,713 shares in the last quarter. 87.96% of the stock is currently owned by hedge funds and other institutional investors.
Insiders Place Their Bets
In related news, SVP Rodney Aulick sold 21,800 shares of Xylem stock in a transaction that occurred on Wednesday, June 5th. The stock was sold at an average price of $139.01, for a total transaction of $3,030,418.00. Following the sale, the senior vice president now directly owns 76,287 shares in the company, valued at $10,604,655.87. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. In other news, CAO Geri-Michelle Mcshane sold 2,278 shares of Xylem stock in a transaction that occurred on Monday, June 10th. The shares were sold at an average price of $138.63, for a total transaction of $315,799.14. Following the completion of the transaction, the chief accounting officer now directly owns 3,536 shares in the company, valued at $490,195.68. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, SVP Rodney Aulick sold 21,800 shares of the company’s stock in a transaction that occurred on Wednesday, June 5th. The stock was sold at an average price of $139.01, for a total value of $3,030,418.00. Following the completion of the sale, the senior vice president now owns 76,287 shares in the company, valued at approximately $10,604,655.87. The disclosure for this sale can be found here. Company insiders own 0.27% of the company’s stock.
Analyst Ratings Changes
View Our Latest Analysis on XYL
Xylem Trading Up 0.5 %
Shares of XYL stock traded up $0.63 during trading hours on Tuesday, reaching $132.16. The company’s stock had a trading volume of 897,218 shares, compared to its average volume of 1,223,909. The company has a current ratio of 1.67, a quick ratio of 1.22 and a debt-to-equity ratio of 0.19. Xylem Inc. has a one year low of $87.59 and a one year high of $146.08. The stock has a market capitalization of $32.04 billion, a P/E ratio of 46.81, a P/E/G ratio of 2.40 and a beta of 1.04. The firm’s fifty day simple moving average is $138.78 and its 200 day simple moving average is $127.28.
Xylem (NYSE:XYL – Get Free Report) last released its quarterly earnings results on Thursday, May 2nd. The industrial products company reported $0.90 earnings per share for the quarter, beating the consensus estimate of $0.84 by $0.06. Xylem had a net margin of 8.34% and a return on equity of 8.95%. The business had revenue of $2.03 billion for the quarter, compared to analysts’ expectations of $2 billion. During the same quarter in the previous year, the business posted $0.72 earnings per share. The firm’s revenue for the quarter was up 40.4% compared to the same quarter last year. Equities research analysts expect that Xylem Inc. will post 4.25 EPS for the current year.
Xylem Dividend Announcement
The company also recently disclosed a quarterly dividend, which was paid on Thursday, June 27th. Shareholders of record on Thursday, May 30th were given a dividend of $0.36 per share. The ex-dividend date was Thursday, May 30th. This represents a $1.44 annualized dividend and a yield of 1.09%. Xylem’s payout ratio is 51.25%.
Xylem Company Profile
Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.
Recommended Stories
- Five stocks we like better than Xylem
- What is the Euro STOXX 50 Index?
- RXO Shares Surge Following New Acquisition Deal
- The Role Economic Reports Play in a Successful Investment Strategy
- 3 Stock Dips Insiders Are Buying: Vestis, Shenandoah, Treace
- What Do S&P 500 Stocks Tell Investors About the Market?
- Biotech Stock Breakout: IBB Eyes Resistance with Amgen and Vertex
Want to see what other hedge funds are holding XYL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Xylem Inc. (NYSE:XYL – Free Report).
Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.